ARK Genomic Revolution ETF (ARKG), issued by ARK, reported 33 long positions and $1.2B in net assets in its Apr 2026 N-PORT filing. The ten largest positions account for 58.79% of net assets.
Reporting period: 30 Apr 2026 · 8 filings on file · N-PORT is filed monthly and published quarterly, roughly 60 days in arrears
Net assets
$1.2B
As of Apr 2026
Positions
33
Long positions in the filing
Top 10 weight
58.79%
Top 25: 92.99%
Effective holdings
21
Concentrated
Cash
0.00%
Share of net assets
Securities on loan
12.7315%
9 positions on loan
Sector exposure
3 sectors · Apr 2026
Health Care76.34%
Technology23.53%
Funds0.13%
Ten largest holdings
Top 10 of 33 positions · Apr 2026
Ten largest holdings reported by ARKG as of 30 Apr 2026
#
Security
CUSIP
Value
% of net assets
1
TEMPUS AI INC-CL A
88023B103
$116.4M
9.42%
2
TWIST BIOSCIENCE CORP
90184D100
$111.1M
8.99%
3
CRISPR THERAPEUTICS AG
000000000
$110.1M
8.91%
4
10X GENOMICS INC-CLASS A
88025U109
$71.3M
5.77%
5
BEAM THERAPEUTICS INC
07373V105
$67.1M
5.43%
6
ABSCI CORP
00091E109
$59.1M
4.78%
7
NATERA INC
632307104
$50.2M
4.07%
8
ILLUMINA INC
452327109
$49.8M
4.03%
9
INTELLIA THERAPEUTICS INC
45826J105
$47.2M
3.82%
10
PERSONALIS INC
71535D106
$44.3M
3.58%
Full holdings, position changes between periods, fund overlap, cross-fund crowding and securities lending detail for ARKG are in the ETF X-Ray dashboard.